Certified by Founder
Lodge
Antiverse
start up
United Kingdom
- Cardiff, Wales
- 03/03/2023
- Unknown
- $3,000,000
Antiverse is building a world-first computational antibody drug discovery platform. We combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in weeks.
- Industry Pharmaceutical Manufacturing
- Website https://www.antiverse.io/
- LinkedIn https://www.linkedin.com/company/antiverse/
Related People
Murat TunaboyluFounder
United Kingdom -
Cardiff, Wales
CEO of Antiverse, background in software engineering and bioinformatics. Mid-career developed high-frequency trading systems. After switching to biotech, built cell imaging software and lab robots to accelerate cancer research and automated Thermo Fisher Scientific’s gene synthesis workflows. Co-founded consultancy and biotech companies Svarlight and Antiverse.
Currently focusing on to realise Antiverse’s mission: engineering the future of drug discovery.
Ciphero | $2,500,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)
StretchSense | $2,300,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ethereal Exploration Guild | $21,000,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)